Reprogramming of Energy Metabolism in Response to Radiotherapy in Head and Neck Squamous Cell Carcinoma

Reprogramming of Energy Metabolism in Response to Radiotherapy in Head and Neck Squamous Cell Carcinoma

Head and neck cancer (HNC) is the sixth cause of cancer-related death worldwide. Head and neck squamous cells carcinoma (HNSCC) is the most frequent subtype of HNC. The development of HNSCC is associated to alcohol consumption, smoking or infection by high-risk human Papillomavirus (HR-HPV). Althoug...

Full description

Bibliographic Details
Main Authors:	Alfredo Cruz-Gregorio, Imelda Martínez-Ramírez, José Pedraza-Chaverri, Marcela Lizano
Format:	Article
Language:	English
Published:	MDPI AG 2019-02-01
Series:	Cancers
Subjects:	HNSCC HR-HPV radiotherapy reprogramming of energy metabolism metabolic therapy oxidative stress
Online Access:	https://www.mdpi.com/2072-6694/11/2/182

Similar Items

E6 Oncoproteins from High-Risk Human Papillomavirus Induce Mitochondrial Metabolism in a Head and Neck Squamous Cell Carcinoma Model
by: Alfredo Cruz-Gregorio, et al.
Published: (2019-08-01)

Head and Neck Squamous Cell Carcinoma in Elderly Patients: Role of Radiotherapy and Chemotherapy
by: Morena Fasano, et al.
Published: (2022-01-01)

Hypofractionated Radiotherapy Upregulates Several Immune Checkpoint Molecules in Head and Neck Squamous Cell Carcinoma Cells Independently of the HPV Status While ICOS-L Is Upregulated Only on HPV-Positive Cells
by: Sebastian Wimmer, et al.
Published: (2021-08-01)

Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma
by: Sharon Changshan Wu, et al.
Published: (2021-11-01)

Associations of GWAS-Identified Risk Loci with Progression, Efficacy and Toxicity of Radiotherapy of Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy
by: Li Q, et al.
Published: (2021-09-01)

Metabolic Reprogramming in Cancer: Role of HPV 16 Variants
by: Adán Arizmendi-Izazaga, et al.
Published: (2021-03-01)

Prognostic value of lipid metabolism‐related genes in head and neck squamous cell carcinoma
by: Ying Xiong, et al.
Published: (2021-03-01)

Phase I feasibility study of Olaparib in combination with loco-regional radiotherapy in head and neck squamous cell carcinoma
by: Arash Navran, et al.
Published: (2024-01-01)

Perspectives of lipid metabolism reprogramming in head and neck squamous cell carcinoma: An overview
by: Xiangwan Miao, et al.
Published: (2022-09-01)

Exploring the roles of HPV16 variants in head and neck squamous cell carcinoma: current challenges and opportunities
by: Daniela Cochicho, et al.
Published: (2021-11-01)

Lipid metabolism reprogramming in head and neck cancer
by: Jinfeng Liang, et al.
Published: (2023-10-01)

New concepts for translational head and neck oncology: lessons from HPV-related oropharyngeal squamous cell carcinomas
by: Efterpi eKostareli, et al.
Published: (2012-04-01)

Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments
by: Tycho de Bakker, et al.
Published: (2022-01-01)

Can Intensity-Modulated-Radiotherapy Reduce Toxicity in Head and Neck Squamous Cell Carcinoma?
by: Julie van der Veen, et al.
Published: (2017-10-01)

Multifunctional nanocomposites DDMplusAF inhibit the proliferation and enhance the radiotherapy of breast cancer cells via modulating tumor-promoting factors and metabolic reprogramming
by: Noura M. Thabet, et al.
Published: (2022-05-01)

MicroRNAs: Their Role in Metabolism, Tumor Microenvironment, and Therapeutic Implications in Head and Neck Squamous Cell Carcinoma
by: Shine-Gwo Shiah, et al.
Published: (2021-11-01)

IgG levels in Human Papillomavirus Infection Associated with Clinical Stage of Head and Neck Squamous Cell Carcinoma
by: Yussy Afriani Dewi, et al.
Published: (2021-09-01)

Association of Inflammation-Related Gene Polymorphisms With Susceptibility and Radiotherapy Sensitivity in Head and Neck Squamous Cell Carcinoma Patients in Northeast China
by: Ying Li, et al.
Published: (2021-06-01)

The prognostic value of LAYN in HPV-related head and neck squamous cell carcinoma and its influence on immune cell infiltration
by: Qingjuan Chen, et al.
Published: (2024-03-01)

Prediction of residual disease using circulating DNA detection after potentiated radiotherapy for locally advanced head and neck cancer (NeckTAR): a study protocol for a prospective, multicentre trial
by: Angeline Ginzac, et al.
Published: (2023-07-01)

Understanding the Roles of the NSD Protein Methyltransferases in Head and Neck Squamous Cell Carcinoma
by: Madhavi Murali, et al.
Published: (2022-11-01)

Stress associated gene expression in blood cells is related to outcome in radiotherapy treated head and neck cancer patients
by: Bøhn Siv K, et al.
Published: (2012-09-01)

p63 Directs Subtype-Specific Gene Expression in HPV+ Head and Neck Squamous Cell Carcinoma
by: Alexandra Ruth Glathar, et al.
Published: (2022-05-01)

Fusobacterium nucleatum-triggered purine metabolic reprogramming drives tumorigenesis in head and neck carcinoma
by: Feiran Li, et al.
Published: (2023-07-01)

Epidemiological Study of p16 Incidence in Head and Neck Squamous Cell Carcinoma 2005–2015 in a Representative Northern European Population
by: Mari Mylly, et al.
Published: (2022-11-01)

The Role of HPV in Determining Treatment, Survival, and Prognosis of Head and Neck Squamous Cell Carcinoma
by: Imogen Sharkey Ochoa, et al.
Published: (2022-09-01)

The Effect of Radiotherapy on Cell Survival and Inflammatory Cytokine and Chemokine Secretion in a Co-Culture Model of Head and Neck Squamous Cell Carcinoma and Normal Cells
by: Sybilla Matuszczak, et al.
Published: (2023-06-01)

PRINS lncRNA Is a New Biomarker Candidate for HPV Infection and Prognosis of Head and Neck Squamous Cell Carcinomas
by: Magda Kopczyńska, et al.
Published: (2020-09-01)

PKM2 Modulation in Head and Neck Squamous Cell Carcinoma
by: Verena Boschert, et al.
Published: (2022-01-01)

Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic response
by: Sean P. Korpela, et al.
Published: (2021-01-01)

Gene Expression Profiles of Methyltransferases and Demethylases Associated with Metastasis, Tumor Invasion, CpG73 Methylation, and HPV Status in Head and Neck Squamous Cell Carcinoma
by: Larisa Goričan, et al.
Published: (2023-05-01)

Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report
by: Laura Deborah Locati, et al.
Published: (2022-01-01)

Organotypic Co-Cultures as a Novel 3D Model for Head and Neck Squamous Cell Carcinoma
by: Luca Engelmann, et al.
Published: (2020-08-01)

Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma
by: Bangrong Cao, et al.
Published: (2018-02-01)

Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer
by: Sonia N. Whang, et al.
Published: (2015-09-01)

HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial
by: Joris B. W. Elbers, et al.
Published: (2023-06-01)

Genomic Landscapes of EBV-Associated Nasopharyngeal Carcinoma vs. HPV-Associated Head and Neck Cancer
by: Hoi-Lam Ngan, et al.
Published: (2018-06-01)

Carbon Ion Radiotherapy Evokes a Metabolic Reprogramming and Individualized Response in Prostate Cancer
by: Renli Ning, et al.
Published: (2021-12-01)

Zinc Finger Proteins in Head and Neck Squamous Cell Carcinomas: ZNF540 May Serve as a Biomarker
by: Joanna Sobocińska, et al.
Published: (2022-12-01)

Infiltration of FoxP3+ Regulatory T Cells is a Strong and Independent Prognostic Factor in Head and Neck Squamous Cell Carcinoma
by: Imelda Seminerio, et al.
Published: (2019-02-01)